ORAMED PHARMACEUTICALS INC. Quarterly Selling and Marketing Expense in USD from Q3 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Oramed Pharmaceuticals Inc. quarterly Selling and Marketing Expense history and growth rate from Q3 2021 to Q3 2023.
  • Oramed Pharmaceuticals Inc. Selling and Marketing Expense for the quarter ending September 30, 2023 was -$663K, a 243% decline year-over-year.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$663K -$1.13M -243% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $192K -$188K -49.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $184K -$406K -68.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $2.33M $463K +$291K +169% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.04M $380K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $590K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $898K Sep 1, 2021 Dec 31, 2021 10-QT 2022-03-30
Q3 2021 $172K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.